MHRA approves Novo Nordisk’s semaglutide to cut cardiovascular risk
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication of Novo Nordisk’s semaglutide, marketed as…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication of Novo Nordisk’s semaglutide, marketed as…
US-based cardiology biotech Cardurion Pharmaceuticals has raised $260m in Series B financing to advance its drug pipeline. The proceeds will…
Novo Nordisk has said it will take a DKr5.7bn ($816m) hit after its acquired drug ocedurenone flopped in the Phase…
Tectonic Therapeutic has completed a reverse merger with Avrobio and will begin trading on the Nasdaq global market as Tectonic…
Clinical-stage biotechnology company Marea Therapeutics has launched with funding of $190m secured through combined Series A and B rounds to…
AstraZeneca has highlighted both the economic and environmental benefits of implementing early, targeted screening for chronic kidney disease (CKD). CKD…
The European Commission (EC) has granted orphan medicinal product designation for Rocket Pharmaceuticals’ RP-A601 gene therapy candidate to treat plakophilin-2…
AstraZeneca has incorporated a new target for heart failure treatment into its discovery portfolio through its ongoing collaboration with BenevolentAI.…
Cytokinetics has announced positive Phase III trial results with its lead drug aficamten being explored as a treatment for a…
Pint Pharma has announced that Mexico's Federal Commission for Protection against Health Risks (COFEPRIS) has granted approval for Orladeyo (berotralstat)…